Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases
- PMID: 22301495
- PMCID: PMC3715127
- DOI: 10.1097/PAS.0b013e318240590a
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases
Abstract
Gamma heavy-chain disease (gHCD) is defined as a lymphoplasmacytic neoplasm that produces an abnormally truncated immunoglobulin gamma heavy-chain protein that lacks associated light chains. There is scant information in the literature regarding the morphologic findings in this rare disorder, but cases have often been reported to resemble lymphoplasmacytic lymphoma (LPL). To clarify the spectrum of lymphoproliferative disorders that may be associated with gHCD, this study reports the clinical, morphologic, and phenotypic findings in 13 cases of gHCD involving lymph nodes (n=7), spleen (n=2), bone marrow (n=8), or other extranodal tissue biopsies (n=3). Clinically, patients showed a female predominance (85%) with frequent occurrence of autoimmune disease (69%). Histologically, 8 cases (61%) contained a morphologically similar neoplasm of small lymphocytes, plasmacytoid lymphocytes, and plasma cells that was difficult to classify with certainty, whereas the remaining 5 cases (39%) showed the typical features of one of several other well-defined entities in the 2008 WHO classification. This report demonstrates that gHCD is associated with a variety of underlying lymphoproliferative disorders but most often shows features that overlap with cases previously reported as "vaguely nodular, polymorphous" LPL. These findings also provide practical guidance for the routine evaluation of small B-cell neoplasms with plasmacytic differentiation that could represent a heavy-chain disease and give suggestions for an improved approach to the WHO classification of gHCD.
Figures




Similar articles
-
Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma.Haematologica. 2014 Sep;99(9):e154-5. doi: 10.3324/haematol.2014.108688. Epub 2014 May 23. Haematologica. 2014. PMID: 24859878 Free PMC article. No abstract available.
-
Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.Medicine (Baltimore). 1989 Nov;68(6):321-35. Medicine (Baltimore). 1989. PMID: 2509855 Review.
-
Gamma Heavy Chain Disease with T-cell Large Granular Lymphocytic Leukemia: A Case Report and Review of the Literature.Intern Med. 2016;55(4):399-403. doi: 10.2169/internalmedicine.55.5042. Epub 2016 Feb 15. Intern Med. 2016. PMID: 26875967 Review.
-
Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.Am J Surg Pathol. 2003 Aug;27(8):1104-13. doi: 10.1097/00000478-200308000-00007. Am J Surg Pathol. 2003. PMID: 12883242
-
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.Haematologica. 2014 Mar;99(3):497-504. doi: 10.3324/haematol.2013.091702. Epub 2013 Oct 18. Haematologica. 2014. PMID: 24143001 Free PMC article.
Cited by
-
Gamma heavy chain disease associated with rheumatoid arthritis: a case report.J Med Case Rep. 2021 Mar 17;15(1):121. doi: 10.1186/s13256-021-02696-7. J Med Case Rep. 2021. PMID: 33726782 Free PMC article.
-
Monoclonal gammopathy in systemic lupus erythematosus is associated with distinctive clinical course, malignancy and mortality rate: a single-centre retrospective cohort study.Lupus Sci Med. 2024 Aug 30;11(2):e001248. doi: 10.1136/lupus-2024-001248. Lupus Sci Med. 2024. PMID: 39216876 Free PMC article.
-
Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).J Clin Exp Hematop. 2019 Sep 30;59(3):119-123. doi: 10.3960/jslrt.19008. Epub 2019 Aug 8. J Clin Exp Hematop. 2019. PMID: 31391403 Free PMC article.
-
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29326807 Free PMC article. Review.
-
MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12. Mod Pathol. 2015. PMID: 25216226
References
-
- Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274–2280. - PubMed
-
- Amakawa R, Ohno H, Fukuhara S. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin’s lymphoma. Int J Hematol. 1999;69:65–69. - PubMed
-
- Andriko JA, Swerdlow SH, Aguilera NI, et al. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol. 2001;25:742–751. - PubMed
-
- Cogne M, Bakhshi A, Korsmeyer SJ, et al. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease. J Immunol. 1988;141:1738–1744. - PubMed
-
- Cook JR, Aguilera NI, Reshmi-Skarja S, et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14) Hum Pathol. 2004;35:447–454. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical